US 11865125
APKC inhibitors and methods of treating a neurodegenerative disease or disorder
granted A61KA61K31/122A61K31/194
Quick answer
US patent 11865125 (APKC inhibitors and methods of treating a neurodegenerative disease or disorder) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/122, A61K31/194, A61K31/28, A61K31/675